SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-065535
Filing Date
2021-05-13
Accepted
2021-05-13 08:30:40
Documents
12
Period of Report
2021-05-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2116156d1_8k.htm   iXBRL 8-K 31143
  Complete submission text file 0001104659-21-065535.txt   207370

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ruby-20210512.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ruby-20210512_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ruby-20210512_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2116156d1_8k_htm.xml XML 3721
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 21917346
SIC: 2836 Biological Products, (No Diagnostic Substances)